RAF1 and melanoma: We selected these lines because mutant BRAF is highly sensitive to Hsp90 inhibition although melanoma cells regardless of their BRAF status are also growth inhibited by agents such as 17-AAG, most likely because of depletion of CRAF as well as BRAF, in addition to effects on other client proteins [20, 21].